UNSPSC 51182031: Mesterolone

This classification denotes a therapeutic androgen with the molecular formula C20H32O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0SRQ75X9I9, chemically known as 5alpha-androstan-3-one, 17beta-hydroxy-1alpha-methyl- but generally known as mesterolone, which bears US NIH Compound Identifier 15020. European Medicines Agency schedules Mesterolone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08790MIG.

UNSPSC 51182031 Mesterolone is a Commodity code covering the procurement of mesterolone, a synthetic androgenic anabolic steroid used in pharmaceutical and medical contexts. State and local governments purchase this controlled substance primarily through health departments, correctional facilities, and public health agencies for legitimate therapeutic purposes where clinically indicated. The code spans acquisition of the active pharmaceutical ingredient in various formulations — tablets, injections, and other delivery mechanisms — subject to strict regulatory compliance under the Drug Enforcement Administration scheduling and state pharmacy board oversight. Issuing bodies are predominantly state departments of health, state prison systems, and county detention facilities that maintain medical services for incarcerated populations or administer public health programs requiring hormone-replacement therapy or treatment of hypogonadism in eligible patients.

The source provides no recent state and local contract opportunities under this code. Without posted solicitations, geographic concentration and representative procurement activity cannot be characterized from current market data.